(2E)-1-(2-methoxyphenyl)-3-(5-methylfuran-2-yl)prop-2-en-1-one, 95.0%, 10g

(E)-Ethyl 3-(pyrrolidin-1-yl)acrylate, 95.0%, 5g

Ethyl 5-chloroimidazo[1,2-a]pyridine-3-carboxylate, 95.0%, 100mg

4-(2-Chloro-6-fluoro-3-methylbenzyl)morpholine, 97%, 500mg

n-(4-Methylthiazol-2-yl)propionamide, 95%, 500mg

5-Acetyl-2-bromobenzonitrile, 95.0%, 100mg

(3-Aminobenzofuran-2-yl)(p-tolyl)methanone, 95.0%, 250mg

4-CHLORO-8-ISOPROPYL-2-METHYLSULFANYL-PYRAZOLO[1,5-A][1,3,5]TRIAZINE, 90.0%, 250mg

1-Hexyl-3-méthyl-imidazolium-, hexafluorophosphate, min 99 %, 25 g, emballage en verre

Midecamycin, >98.0%, 250mg

2,4-DICHLORO-5-FLUORO-6-METHYLPYRIMIDINE, 95.0%, 100mg

4-[(3-hydroxyphenyl)amino]-4-oxobutanoic acid, 95.0%, 1g

Tert-butyl n-(2-aminoethyl)-n-cyclopropylcarbamate, 95+%, 5g